Trademark: 88460314
Status Date
Monday, January 9, 2023
Filing Date
Wednesday, June 5, 2019
Published for Opposition
Tuesday, October 8, 2019
Abandoned Date
Monday, January 9, 2023
5 Pharmaceutical in the form of an intravenous emulsion for use as a phospholipid delivery agent for the treatment of endotoxemia and sepsis
Jan 9, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 9, 2023
Abandonment - No Use Statement Filed
May 25, 2022
Notice Of Approval Of Extension Request E-Mailed
May 24, 2022
Sou Extension 5 Granted
May 19, 2022
Sou Extension 5 Filed
May 24, 2022
Case Assigned To Intent To Use Paralegal
May 19, 2022
Sou Teas Extension Received
Nov 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2021
Sou Extension 4 Granted
Nov 18, 2021
Sou Extension 4 Filed
Nov 18, 2021
Sou Teas Extension Received
Jun 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 1, 2021
Sou Extension 3 Granted
Jun 1, 2021
Sou Extension 3 Filed
Jun 1, 2021
Sou Teas Extension Received
Dec 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2020
Sou Extension 2 Granted
Dec 2, 2020
Sou Extension 2 Filed
Dec 2, 2020
Sou Teas Extension Received
May 27, 2020
Notice Of Approval Of Extension Request E-Mailed
May 25, 2020
Sou Extension 1 Granted
May 25, 2020
Sou Extension 1 Filed
May 25, 2020
Sou Teas Extension Received
Dec 3, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 8, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 8, 2019
Published For Opposition
Sep 18, 2019
Notification Of Notice Of Publication E-Mailed
Sep 3, 2019
Approved For Pub - Principal Register
Aug 27, 2019
Assigned To Examiner
Jun 19, 2019
New Application Office Supplied Data Entered
Jun 8, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
